Skip to main content
. Author manuscript; available in PMC: 2009 Jan 6.
Published in final edited form as: Kidney Int. 2008 Jul 16;74(8):1017–1025. doi: 10.1038/ki.2008.346

Figure 7. Combination treatment of sFlt-1 and chloroquine.

Figure 7

(A-B) Renal function of combination treatment. BUN and serum Cr were measured 18 hr after CLP in control group (n = 18), sFlt-1 treatment group, CQ treatment group, and combination treatment group (n = 6∼7 per treatment group). (C-D) Telemetric recordings of mean arterial pressure (MAP) and heart rate (HR) (n = 5∼6 per group) and (E) Survival analysis of combination treatment (n = 15∼17 per group). #, P < 0.05 versus control.